Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_52589 | 87 | 1.82 | Mlig455_059209 | Neo: - Age: - |
Mlig455_059209 {REF} {Length: 2113} {NoTransDecoderORF} {RNA1509_49308} {RNA1310_53726} {RNA815_13935.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.834 | 1.718 | 0.99982 | 1.00000 | |
RegionR2 | 1.882 | 1.718 | 0.14209 | 0.46906 | |
RegionR3 | -2.751 | 1.718 | 0.99958 | 1.00000 | |
RegionR4 | 0.967 | 1.718 | 0.31036 | 0.62503 | |
RegionR5 | 1.693 | 1.718 | 0.10163 | 0.30850 | |
RegionR6 | 1.342 | 1.718 | 0.22741 | 0.80931 | |
RegionR7 | -2.894 | 1.718 | 0.99969 | 1.00000 | |
RegionR8 | 2.596 | 1.718 | 0.13708 | 0.67700 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.561 | 1.718 | 0.99999 | 1.00000 | |
RegenerationR2 | 1.278 | 1.718 | 0.16467 | 0.60261 | |
RegenerationR3 | 3.874 | 1.718 | 0.01826 | 0.24699 | |
RegenerationR4 | 0.654 | 1.718 | 0.55015 | 0.89283 | |
RegenerationR5 | 0.068 | 1.718 | 0.95947 | 1.00000 | |
RegenerationR6 | 1.771 | 1.718 | 0.13119 | 0.44472 | |
RegenerationBL | 1.107 | 1.718 | 0.45605 | 0.82352 | |
RegenerationTP | 2.594 | 1.718 | 0.16771 | 0.59973 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_52589 | 87 | 1.82 | Mlig455_059209 | Neo: - Age: - |
4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_059209 {REF} {Length: 2113} {NoTransDecoderORF} {RNA1509_49308} {RNA1310_53726} {RNA815_13935.1} | |
2. | MligTC455_52253 | 208 | 4.33 | Mlig455_020508 | Neo: - Age: Down-Up-Down |
1.749 | - | - | 0.950 | - | 0.799 | - | Mlig455_020508 {REF} {Length: 2334} {Pfam: TIR domain [PF13676.8, score=72.5]; BTK motif [PF00779.21, score=30.0]; TIR domain [PF01582.22, score=24.8]} {Smed: dd_Smed_v6_4452_0_1, dd_Smed_v6_4452_0_1, [Score=73.6, Expect=2e-13]} {RNA1509_54137} {RNA1310_8917.2, RNA1509_54137} {RNA1509_54137, RNA815_7724} | |
3. | MligTC455_38953 | 457 | 9.51 | Mlig455_038441, Mlig455_038577 | Neo: - Age: - Region-enriched R2: 2.547/0.00161 |
1.747 | - | - | 0.950 | - | - | 0.797 | Mlig455_038441 {REF} {Length: 2170} {Pfam: Acetyl-CoA hydrolase/transferase C-terminal domain [PF13336.8, score=195.7]} {Dmel: FBgn0039737, CG7920, [Score=335, Expect=2e-113]} {Celegans: WBGene00016630, acer-1, ACEtyl-CoA Regulator, [Score=355, Expect=6e-122]} {Smed: dd_Smed_v6_1775_0_1, dd_Smed_v6_1775_0_1, [Score=365, Expect=1e-125]} {RNA1509_16263} {RNA1310_17251} {RNA815_8195} Mlig455_038577 {REF} {Length: 2904} {TRANSSPLICED} {Pfam: Acetyl-CoA hydrolase/transferase C-terminal domain [PF13336.8, score=194.2]; Acetyl-CoA hydrolase/transferase N-terminal domain [PF02550.17, score=83.9]} {Dmel: FBgn0039737, CG7920, [RH, Score=498, Expect=1e-173]} {Celegans: WBGene00016630, acer-1, ACEtyl-CoA Regulator, [RH, Score=506, Expect=3e-177]} {Smed: dd_Smed_v6_1775_0_1, dd_Smed_v6_1775_0_1, [RH, Score=608, Expect=0.0]} {RNA1509_16263} {RNA1310_17251} {RNA815_8195} |
|
4. | MligTC455_17565 | 85 | 1.77 | Mlig455_054318 | Neo: - Age: - Region-enriched R2: 6.111/0.00708 |
1.686 | - | - | - | - | 0.958 | 0.728 | Mlig455_054318 {REF} {Length: 550} {RNA1310_73705} {RNA815_38857} | |
5. | MligTC455_53167 | 621 | 12.93 | Mlig455_035205, Mlig455_035254 | Neo: - Age: - |
TEP1 | 1.684 | - | - | 0.732 | - | 0.952 | - | Mlig455_035205 {REF} {Length: 3182} {Pfam: Domain of unknown function (DUF4062) [PF13271.8, score=42.8]; NACHT domain [PF05729.14, score=19.7]} {Human: ENSG00000129566, TEP1, telomerase associated protein 1, [Score=143, Expect=4e-34]} {Mouse: ENSMUSG00000006281, Tep1, telomerase associated protein 1, [Score=121, Expect=2e-27]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [RH, Score=335, Expect=8e-102]} {RNA1509_45368, RNA1509_7043} {RNA1310_6418, RNA1509_45368} {RNA1509_45368, RNA815_7934} Mlig455_035254 {REF} {Length: 3176} {Pfam: Domain of unknown function (DUF4062) [PF13271.8, score=42.8]; NACHT domain [PF05729.14, score=19.7]; AAA ATPase domain [PF13191.8, score=19.7]} {Human: ENSG00000129566, TEP1, telomerase associated protein 1, [Score=142, Expect=6e-34]} {Mouse: ENSMUSG00000006281, Tep1, telomerase associated protein 1, [Score=119, Expect=1e-26]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [RH, Score=329, Expect=2e-99]} {RNA1509_7043} {RNA1310_6418, RNA1509_7043} {RNA1509_7043, RNA815_7934} |
6. | MligTC455_29770 | 150 | 3.12 | Mlig455_013548, Mlig455_041433 | Neo: - Age: - |
MAP3K19 | 0.976 | - | - | - | - | 0.976 | - | Mlig455_013548 {REF} {Length: 571} {NoTransDecoderORF} {RNA1509_6748} {RNA1310_95865} {RNA815_24422.1} Mlig455_041433 {REF} {Length: 1974} {Pfam: Protein kinase domain [PF00069.27, score=69.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.3]} {Human: ENSG00000176601, MAP3K19, mitogen-activated protein kinase kinase kinase 19, [Score=84.0, Expect=3e-19]} {Mouse: ENSMUSG00000051590, Map3k19, mitogen-activated protein kinase kinase kinase 19, [Score=80.5, Expect=3e-18]} {Dmel: FBgn0266465, GckIII, Germinal centre kinase III, [Score=70.1, Expect=8e-15]} {Celegans: WBGene00003144, max-2, Serine/threonine-protein kinase max-2, [Score=61.2, Expect=5e-12]} {Smed: dd_Smed_v6_2030_0_29, dd_Smed_v6_2030_0_29, [Score=75.1, Expect=3e-18]} {RNA1509_48626} {RNA1310_17852.1} {RNA815_25899} |
7. | MligTC455_53689 | 399 | 8.3 | Mlig455_012608 | Neo: Neoblast Age: - |
RPF2 | 0.976 | - | - | 0.976 | - | - | - | Mlig455_012608 {REF} {Length: 2130} {TRANSSPLICED} {Pfam: Brix domain [PF04427.20, score=134.0]} {Human: ENSG00000197498, RPF2, ribosome production factor 2 homolog, [RH, Score=267, Expect=4e-88]} {Mouse: ENSMUSG00000038510, Rpf2, ribosome production factor 2 homolog, [RH, Score=282, Expect=4e-94]} {Dmel: FBgn0038585, Non3, Novel nucleolar protein 3, [RH, Score=254, Expect=4e-83]} {Celegans: WBGene00021830, Y54E10A.10, Ribosome production factor 2 homolog, [RH, Score=233, Expect=2e-75]} {Smed: dd_Smed_v6_2776_0_1, dd_Smed_v6_2776_0_1, [RH, Score=136, Expect=7e-38]} {RNA1509_11141} {RNA1310_23520, RNA1509_11141} {RNA1509_11141, RNA815_12430} |
8. | MligTC455_02580 | 261 | 5.45 | Mlig455_016172 | Neo: - Age: - Region-enriched R5: 1.240/0.02517 |
0.973 | - | - | 0.973 | - | - | - | Mlig455_016172 {REF} {Length: 395} {NoTransDecoderORF} {RNA1509_25902} {RNA1310_12352.1} {RNA815_10334.1} | |
9. | MligTC455_49257 | 739 | 15.4 | Mlig455_033298 | Neo: - Age: - |
MFHAS1 | 0.967 | - | - | - | - | 0.967 | - | Mlig455_033298 {REF} {Length: 1564} {TRANSSPLICED} {Pfam: Leucine rich repeat [PF13855.8, score=64.8]; Leucine Rich repeats (2 copies) [PF12799.9, score=44.5]; Leucine-rich repeat [PF14580.8, score=29.1]} {Human: ENSG00000147324, MFHAS1, malignant fibrous histiocytoma amplified sequence 1, [Score=102, Expect=4e-23]; ENSG00000285022, AC270282.1, malignant fibrous histiocytoma amplified sequence 1, [Score=102, Expect=4e-23]} {Mouse: ENSMUSG00000070056, Mfhas1, malignant fibrous histiocytoma amplified sequence 1, [Score=94.7, Expect=1e-20]} {Dmel: FBgn0263289, scrib, scribbled, [Score=87.8, Expect=2e-18]} {Celegans: WBGene00004929, soc-2, Leucine-rich repeat protein soc-2, [Score=85.1, Expect=8e-18]} {Smed: dd_Smed_v6_11443_0_1, dd_Smed_v6_11443_0_1, [RH, Score=102, Expect=7e-25]} {RNA1509_32286, RNA1509_43570} {RNA1310_22536.1, RNA1509_32286, RNA1509_43570} {RNA1509_32286, RNA1509_43570, RNA815_11933} |
10. | MligTC455_08649 | 67 | 1.4 | Mlig455_030201 | Neo: - Age: - |
0.964 | - | - | 0.964 | - | - | - | Mlig455_030201 {REF} {Length: 1235} {RNA1310_50257} {RNA815_63297} | |
11. | MligTC455_32522 | 134 | 2.8 | Mlig455_040944 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_040944 {REF} {Length: 2473} {RNA1509_46835} {RNA1310_21335.2} {RNA815_21965} | |
12. | MligTC455_46518 | 283 | 5.9 | Mlig455_004530, Mlig455_028532, Mlig455_064722 | Neo: - Age: - |
CHRNA4 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_004530 {REF} {Length: 3050} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=183.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=126.0]} {Human: ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=261, Expect=4e-78]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=250, Expect=7e-74]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=238, Expect=7e-71]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=238, Expect=9e-71]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=254, Expect=4e-77]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=231, Expect=2e-68]} {Smed: dd_Smed_v6_8486_0_1, dd_Smed_v6_8486_0_1, [RH, Score=560, Expect=0.0]} {RNA1509_15763} {RNA1310_13813} {RNA815_7852} Mlig455_028532 {REF} {Length: 6717} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=182.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=125.6]} {Human: ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=262, Expect=1e-77]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=250, Expect=3e-73]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=239, Expect=2e-70]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=238, Expect=4e-70]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=255, Expect=1e-76]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=231, Expect=8e-68]} {Smed: dd_Smed_v6_8486_0_1, dd_Smed_v6_8486_0_1, [RH, Score=560, Expect=0.0]} {RNA1509_15763} {RNA1310_13813} {RNA815_7852} Mlig455_064722 {REF} {Length: 349} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Smed: dd_Smed_v6_8486_0_1, dd_Smed_v6_8486_0_1, [Score=75.9, Expect=3e-17]} {RNA1509_15763} {RNA1310_15286} {RNA815_7852} |
13. | MligTC455_46594 | 591 | 12.31 | Mlig455_037738 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.869/0.00006 |
0.963 | - | - | - | - | 0.963 | - | Mlig455_037738 {REF} {Length: 2043} {RNA1509_42203} {RNA1310_65422.3, RNA1509_42203} {RNA1509_42203, RNA815_30338} | |
14. | MligTC455_38062 | 26 | 0.55 | Mlig455_015619 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_015619 {REF} {Length: 1624} {NoTransDecoderORF} {RNA1509_29114} {RNA1310_21909.2} {RNA815_54554} | |
15. | MligTC455_45537 | 189 | 3.94 | Mlig455_060669 | Neo: - Age: Up-Down-Up |
NPR1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_060669 {REF} {Length: 2668} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=200.8]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=56.3]; Protein kinase domain [PF00069.27, score=41.4]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=382, Expect=4e-123]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=375, Expect=9e-121]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=394, Expect=7e-128]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=377, Expect=9e-126]} {Dmel: FBgn0051183, CG31183, [Score=374, Expect=8e-118]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=348, Expect=1e-109]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=429, Expect=4e-141]} {RNA1509_50551} {RNA1310_4016.1} {RNA815_2101.1} |
16. | MligTC455_31817 | 509 | 10.6 | Mlig455_040709, Mlig455_064581 | Neo: - Age: - Region-enriched R8: 2.108/0.01175 |
C16orf58 | 0.96 | - | - | 0.960 | - | - | - | Mlig455_040709 {REF} {Length: 2089} {TRANSSPLICED} {Pfam: Vitamin B6 photo-protection and homoeostasis [PF04884.16, score=287.5]} {Human: ENSG00000140688, C16orf58, chromosome 16 open reading frame 58, [RH, Score=242, Expect=6e-75]} {Mouse: ENSMUSG00000030780, BC017158, cDNA sequence BC017158, [RH, Score=241, Expect=8e-75]} {Dmel: FBgn0032700, CG10338, [RH, Score=212, Expect=5e-64]} {Smed: dd_Smed_v6_6378_0_4, dd_Smed_v6_6378_0_4, [RH, Score=283, Expect=1e-91]} {RNA1509_38646} {RNA1310_22643.2} {RNA815_12880} Mlig455_064581 {REF} {Length: 5185} {Smed: dd_Smed_v6_6378_0_4, dd_Smed_v6_6378_0_4, [Score=47.0, Expect=1e-06]} {RNA1509_45578, RNA1509_49619} {RNA1310_9836, RNA1509_45578} {RNA1509_45578, RNA815_16395} |
17. | MligTC455_36140 | 362 | 7.54 | Mlig455_067735 | Neo: - Age: logFC(26M/2M)=-0.366 |
MGAT1 | 0.96 | - | - | - | - | - | 0.960 | Mlig455_067735 {REF} {Length: 2083} {Pfam: GNT-I family [PF03071.17, score=235.7]; Glycosyltransferase like family 2 [PF13641.8, score=24.3]; N-acetylglucosaminyltransferase II (MGAT2) [PF05060.16, score=20.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=166, Expect=7e-46]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=181, Expect=1e-51]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=5e-48]} {Celegans: WBGene00001637, gly-12, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=171, Expect=6e-48]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=159, Expect=8e-44]} {RNA1310_12882.2} {RNA815_5789.1} |
18. | MligTC455_11478 | 98 | 2.05 | Mlig455_037891 | Neo: - Age: - |
0.959 | - | - | - | - | - | 0.959 | Mlig455_037891 {REF} {Length: 868} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=53.3]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=59.3, Expect=3e-11]} {RNA1310_49297} {RNA815_57902} | |
19. | MligTC455_15493 | 109 | 2.26 | Mlig455_005712 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_005712 {REF} {Length: 1705} {RNA1509_47692} {RNA1310_24839} {RNA815_13783} | |
20. | MligTC455_37253 | 147 | 3.07 | Mlig455_058805 | Neo: - Age: - |
ZFAND2B | 0.958 | - | - | 0.958 | - | - | - | Mlig455_058805 {REF} {Length: 1475} {TRANSSPLICED} {Pfam: AN1-like Zinc finger [PF01428.18, score=74.1]} {Human: ENSG00000158552, ZFAND2B, zinc finger AN1-type containing 2B, [RH, Score=197, Expect=3e-62]} {Mouse: ENSMUSG00000026197, Zfand2b, zinc finger, AN1 type domain 2B, [RH, Score=192, Expect=1e-60]} {Dmel: FBgn0031535, CG12795, [RH, Score=176, Expect=1e-54]} {Celegans: WBGene00000097, aip-1, Arsenite Inducible Protein, [RH, Score=122, Expect=2e-34]} {Smed: dd_Smed_v6_9366_0_1, dd_Smed_v6_9366_0_1, [RH, Score=131, Expect=7e-38]} {RNA1509_12174} {RNA1310_22891.1} {RNA815_19532} |
21. | MligTC455_37254 | 145 | 3.01 | Mlig455_058857 | Neo: - Age: - |
ZFAND2B | 0.957 | - | - | 0.957 | - | - | - | Mlig455_058857 {REF} {Length: 1471} {TRANSSPLICED} {Pfam: AN1-like Zinc finger [PF01428.18, score=74.1]} {Human: ENSG00000158552, ZFAND2B, zinc finger AN1-type containing 2B, [RH, Score=196, Expect=8e-62]} {Mouse: ENSMUSG00000026197, Zfand2b, zinc finger, AN1 type domain 2B, [RH, Score=192, Expect=3e-60]} {Dmel: FBgn0031535, CG12795, [RH, Score=179, Expect=2e-55]} {Celegans: WBGene00000097, aip-1, Arsenite Inducible Protein, [RH, Score=122, Expect=2e-34]} {Smed: dd_Smed_v6_9366_0_1, dd_Smed_v6_9366_0_1, [RH, Score=134, Expect=6e-39]} {RNA1509_12174} {RNA1310_22891.1} {RNA815_19532} |
22. | MligTC455_44309 | 91 | 1.9 | Mlig455_022755 | Neo: - Age: - |
0.955 | - | - | - | - | - | 0.955 | Mlig455_022755 {REF} {Length: 2595} {NoTransDecoderORF} {RNA1310_141520} | |
23. | MligTC455_15933 | 79 | 1.65 | Mlig455_045044 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_045044 {REF} {Length: 1551} {RNA1509_16354} {RNA1310_48957} {RNA815_45783} | |
24. | MligTC455_22597 | 62 | 1.3 | Mlig455_063778 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_063778 {REF} {Length: 2886} {Pfam: Integrase core domain [PF00665.28, score=49.6]; gag-polyprotein putative aspartyl protease [PF13975.8, score=29.5]; Aspartyl protease [PF13650.8, score=25.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=22.0]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=69.7, Expect=4e-12]} {RNA1509_25667} {RNA1310_2462} {RNA815_755} | |
25. | MligTC455_38629 | 14 | 0.29 | Mlig455_038964 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_038964 {REF} {Length: 1633} {NoTransDecoderORF} {RNA1509_57189} {RNA1310_356.1} {RNA815_52888} | |
26. | MligTC455_17959 | 100 | 2.07 | Mlig455_007716 | Neo: - Age: Down-Up-Down |
0.952 | - | - | - | - | - | 0.952 | Mlig455_007716 {REF} {Length: 2235} {Pfam: Plectin repeat [PF00681.22, score=24.7]} {RNA1509_53557} {RNA1310_11354} {RNA815_18566} | |
27. | MligTC455_31948 | 70 | 1.45 | Mlig455_007378, Mlig455_013863, Mlig455_017814, Mlig455_029704 | Neo: - Age: - |
KCTD1 | 0.952 | - | - | 0.952 | - | - | - | Mlig455_007378 {REF} {Length: 1142} {TRANSSPLICED} {Human: ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [Score=69.3, Expect=4e-12]} {Mouse: ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [Score=69.3, Expect=2e-12]} {RNA1310_16403.1} {RNA815_36960} Mlig455_013863 {REF} {Length: 108} {NoTransDecoderORF} {RNA1509_35604} {RNA1310_61034} {RNA815_12032.1} Mlig455_017814 {REF} {Length: 2652} {Human: ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [Score=72.0, Expect=8e-13]} {Mouse: ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [Score=72.4, Expect=5e-13]} {RNA1509_35604} {RNA1310_16403.1} {RNA815_36960} Mlig455_029704 {REF} {Length: 726} {Human: ENSG00000134504, KCTD1, potassium channel tetramerization domain containing 1, [Score=50.8, Expect=9e-07]} {Mouse: ENSMUSG00000036225, Kctd1, potassium channel tetramerisation domain containing 1, [Score=50.8, Expect=7e-07]} {RNA1310_16403.1} {RNA815_43647} |
28. | MligTC455_11480 | 90 | 1.88 | Mlig455_039020 | Neo: - |
AVP | 0.951 | - | - | - | - | - | 0.951 | Mlig455_039020 {REF} {Length: 1893} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=53.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=53.1, Expect=6e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=56.6, Expect=2e-10]} {RNA1509_55830} {RNA1310_31994} {RNA815_9217} |
29. | MligTC455_38067 | 80 | 1.67 | Mlig455_046788 | Neo: - Age: - |
ANO7 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_046788 {REF} {Length: 4898} {TRANSSPLICED} {Pfam: Calcium-activated chloride channel [PF04547.14, score=418.0]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=88.5]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=24.9]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=300, Expect=8e-87]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=303, Expect=9e-89]} {Dmel: FBgn0036235, CG6938, [Score=268, Expect=1e-74]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=412, Expect=5e-130]} {Smed: dd_Smed_v6_5046_0_1, dd_Smed_v6_5046_0_1, [Score=280, Expect=8e-81]} {RNA1509_23151} {RNA1310_3473} {RNA815_7212} |